ID   CDK10_HUMAN             Reviewed;         360 AA.
AC   Q15131; A8K370; A8K8I6; A8MXU6; B3KQJ3; B7Z420; D3DX82; D3DX83;
AC   Q0VGZ7; Q15130; Q6PJC0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Cyclin-dependent kinase 10;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 10;
DE   AltName: Full=Serine/threonine-protein kinase PISSLRE;
GN   Name=CDK10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=8208557;
RA   Grana X., Claudio P.P., De Luca A., Sang N., Giordano A.;
RT   "PISSLRE, a human novel CDC2-related protein kinase.";
RL   Oncogene 9:2097-2103(1994).
RN   [2]
RP   SEQUENCE REVISION.
RA   Grana X., Claudio P.P., De Luca A., Sang N., Giordano A.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8084611;
RA   Brambilla R., Draetta G.;
RT   "Molecular cloning of PISSLRE, a novel putative member of the cdk
RT   family of protein serine/threonine kinases.";
RL   Oncogene 9:3037-3041(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10036189; DOI=10.1006/geno.1998.5676;
RA   Crawford J., Ianzano L., Savino M., Whitmore S., Cleton-Jansen A.-M.,
RA   Settasatiani C., D'Apolito M., Seshadri R., Pronk J.C., Auerbach A.D.,
RA   Verlander P.C., Mathew C.G., Tipping A.J., Doggett N.A., Zelante L.,
RA   Callen D.F., Savoia A.;
RT   "The PISSLRE gene: structure, exon skipping, and exclusion as tumor
RT   suppressor in breast cancer.";
RL   Genomics 56:90-97(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 5; 6 AND 7).
RC   TISSUE=Brain, Colon, Ovary, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Bechtel S., Schupp I., Duda A., Wellenreuther R., Mehrle A.,
RA   Ruschke V., Poustka A., Wiemann S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-196, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-196, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH FAM58A.
RX   PubMed=24218572; DOI=10.1073/pnas.1306814110;
RA   Guen V.J., Gamble C., Flajolet M., Unger S., Thollet A., Ferandin Y.,
RA   Superti-Furga A., Cohen P.A., Meijer L., Colas P.;
RT   "CDK10/cyclin M is a protein kinase that controls ETS2 degradation and
RT   is deficient in STAR syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:19525-19530(2013).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-96; SER-168; HIS-342 AND TYR-358.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Cyclin-dependent kinase that phosphorylates the
CC       transcription factor ETS2 (in vitro) and positively controls its
CC       proteasomal degradation (in cells). {ECO:0000269|PubMed:24218572}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:24218572}.
CC   -!- SUBUNIT: Heterodimer with FAM58A/Cyclin-M, the interaction is
CC       required for kinase activity. Interacts with ETS2.
CC       {ECO:0000269|PubMed:24218572}.
CC   -!- INTERACTION:
CC       P15036:ETS2; NbExp=3; IntAct=EBI-11507283, EBI-1646991;
CC       Q8N1B3:FAM58A; NbExp=5; IntAct=EBI-11507283, EBI-3925043;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1646959, EBI-352572;
CC       Q13526:PIN1; NbExp=5; IntAct=EBI-1646959, EBI-714158;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q15131-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15131-2; Sequence=VSP_021642;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q15131-3; Sequence=VSP_021642, VSP_021643;
CC       Name=4;
CC         IsoId=Q15131-4; Sequence=VSP_021642, VSP_021644;
CC       Name=5;
CC         IsoId=Q15131-5; Sequence=VSP_054969, VSP_054972, VSP_054973;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q15131-6; Sequence=VSP_054969, VSP_054970, VSP_054971;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=Q15131-7; Sequence=VSP_021642, VSP_054972;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L33264; AAA60092.2; -; mRNA.
DR   EMBL; X78342; CAA55137.1; -; mRNA.
DR   EMBL; AJ010341; CAB37619.1; -; Genomic_DNA.
DR   EMBL; AJ010342; CAB37619.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010343; CAB37619.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010344; CAB37619.1; JOINED; Genomic_DNA.
DR   EMBL; AM392903; CAL37781.1; -; mRNA.
DR   EMBL; AK075036; BAG52055.1; -; mRNA.
DR   EMBL; AK290485; BAF83174.1; -; mRNA.
DR   EMBL; AK292351; BAF85040.1; -; mRNA.
DR   EMBL; AK296631; BAH12406.1; -; mRNA.
DR   EMBL; AM393177; CAL38055.1; -; mRNA.
DR   EMBL; AM393204; CAL38082.1; -; mRNA.
DR   EMBL; AC010538; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471184; EAW66701.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66703.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66704.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66705.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66706.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66707.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66708.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66710.1; -; Genomic_DNA.
DR   EMBL; BC017342; AAH17342.1; -; mRNA.
DR   EMBL; BC025301; AAH25301.1; -; mRNA.
DR   CCDS; CCDS10984.2; -. [Q15131-1]
DR   CCDS; CCDS32514.2; -. [Q15131-4]
DR   PIR; S49330; S49330.
DR   RefSeq; NP_001092003.2; NM_001098533.2. [Q15131-3]
DR   RefSeq; NP_001153839.1; NM_001160367.1. [Q15131-2]
DR   RefSeq; NP_443713.2; NM_052987.3. [Q15131-4]
DR   RefSeq; NP_443714.3; NM_052988.4. [Q15131-1]
DR   RefSeq; XP_016879297.1; XM_017023808.1. [Q15131-2]
DR   RefSeq; XP_016879298.1; XM_017023809.1. [Q15131-3]
DR   RefSeq; XP_016879299.1; XM_017023810.1. [Q15131-4]
DR   UniGene; Hs.699177; -.
DR   ProteinModelPortal; Q15131; -.
DR   SMR; Q15131; -.
DR   BioGrid; 114128; 15.
DR   IntAct; Q15131; 16.
DR   STRING; 9606.ENSP00000338673; -.
DR   ChEMBL; CHEMBL1795191; -.
DR   iPTMnet; Q15131; -.
DR   PhosphoSitePlus; Q15131; -.
DR   BioMuta; CDK10; -.
DR   DMDM; 6226784; -.
DR   EPD; Q15131; -.
DR   MaxQB; Q15131; -.
DR   PaxDb; Q15131; -.
DR   PeptideAtlas; Q15131; -.
DR   PRIDE; Q15131; -.
DR   DNASU; 8558; -.
DR   Ensembl; ENST00000353379; ENSP00000338673; ENSG00000185324. [Q15131-1]
DR   Ensembl; ENST00000505473; ENSP00000424415; ENSG00000185324. [Q15131-4]
DR   Ensembl; ENST00000617879; ENSP00000484357; ENSG00000185324. [Q15131-4]
DR   GeneID; 8558; -.
DR   KEGG; hsa:8558; -.
DR   UCSC; uc002fod.4; human. [Q15131-1]
DR   CTD; 8558; -.
DR   DisGeNET; 8558; -.
DR   GeneCards; CDK10; -.
DR   HGNC; HGNC:1770; CDK10.
DR   HPA; HPA059634; -.
DR   HPA; HPA067060; -.
DR   MIM; 603464; gene.
DR   neXtProt; NX_Q15131; -.
DR   OpenTargets; ENSG00000185324; -.
DR   PharmGKB; PA26307; -.
DR   eggNOG; KOG0663; Eukaryota.
DR   eggNOG; ENOG410XQ50; LUCA.
DR   GeneTree; ENSGT00830000128256; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q15131; -.
DR   KO; K02449; -.
DR   OMA; ILKRCQH; -.
DR   OrthoDB; EOG091G048P; -.
DR   PhylomeDB; Q15131; -.
DR   TreeFam; TF101026; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q15131; -.
DR   ChiTaRS; CDK10; human.
DR   GeneWiki; Cyclin-dependent_kinase_10; -.
DR   GenomeRNAi; 8558; -.
DR   PRO; PR:Q15131; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000185324; -.
DR   CleanEx; HS_CDK10; -.
DR   ExpressionAtlas; Q15131; baseline and differential.
DR   Genevisible; Q15131; HS.
DR   GO; GO:0016592; C:mediator complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0007089; P:traversing start control point of mitotic cell cycle; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    360       Cyclin-dependent kinase 10.
FT                                /FTId=PRO_0000085809.
FT   DOMAIN       39    323       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      45     53       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    163    163       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      68     68       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     196    196       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ       1     71       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8208557,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_021642.
FT   VAR_SEQ      48     54       GTYGIVY -> D (in isoform 5 and isoform
FT                                6). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054969.
FT   VAR_SEQ     141    160       KCIVLQVLRGLQYLHRNFII -> RGRGAWGGGMGFMGPCG
FT                                AHL (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054970.
FT   VAR_SEQ     161    360       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054971.
FT   VAR_SEQ     180    194       ADFGLARAYGVPVKP -> GGCNLGQALSLDGTW (in
FT                                isoform 5 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054972.
FT   VAR_SEQ     195    360       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054973.
FT   VAR_SEQ     306    311       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_021643.
FT   VAR_SEQ     329    360       PCEPELMPTFPHHRNKRAAPATSEGQSKRCKP -> RLPIS
FT                                GVCEGCREPG (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8208557}.
FT                                /FTId=VSP_021644.
FT   VARIANT      96     96       P -> L (in dbSNP:rs55819627).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041983.
FT   VARIANT     168    168       N -> S (in dbSNP:rs56340740).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041984.
FT   VARIANT     342    342       R -> H (in dbSNP:rs55757604).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041985.
FT   VARIANT     358    358       C -> Y (in dbSNP:rs56242003).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041986.
SQ   SEQUENCE   360 AA;  41038 MW;  25B28560961103F4 CRC64;
     MAEPDLECEQ IRLKCIRKEG FFTVPPEHRL GRCRSVKEFE KLNRIGEGTY GIVYRARDTQ
     TDEIVALKKV RMDKEKDGIP ISSLREITLL LRLRHPNIVE LKEVVVGNHL ESIFLVMGYC
     EQDLASLLEN MPTPFSEAQV KCIVLQVLRG LQYLHRNFII HRDLKVSNLL MTDKGCVKTA
     DFGLARAYGV PVKPMTPKVV TLWYRAPELL LGTTTQTTSI DMWAVGCILA ELLAHRPLLP
     GTSEIHQIDL IVQLLGTPSE NIWPGFSKLP LVGQYSLRKQ PYNNLKHKFP WLSEAGLRLL
     HFLFMYDPKK RATAGDCLES SYFKEKPLPC EPELMPTFPH HRNKRAAPAT SEGQSKRCKP
//
